Peter E. Grebow
Fondatore presso P. E. Grebow Consulting, Inc.
Profilo
Peter E.
Grebow founded P.
E.
Grebow Consulting, Inc. in 2011, where he is working as President from 2011.
Dr. Grebow also currently works at Q Therapeutics, Inc., as Director from 2011 and MAGiQ Therapeutics, Inc., as Director.
Dr. Grebow also formerly worked at Rebus Holdings, Inc., as Chairman from 2016 to 2018, Optimer Pharmaceuticals LLC, as Independent Director from 2011 to 2013, Complexa, Inc., as Director, Cephalon, Inc., as Executive VP-Worldwide Technical Operations in 2010, Eagle Pharmaceuticals, Inc., as Executive Vice President-Research & Development, and Rhone-Poulenc Rorer Pharmaceuticals, Inc., as Vice President-Drug Development in 1990.
Dr. Grebow received his graduate degree from Rutgers State University of New Jersey, undergraduate degree from Cornell University, and doctorate degree in 1973 from the University of California, Santa Barbara.
Posizioni attive di Peter E. Grebow
| Società | Posizione | Inizio |
|---|---|---|
Q Therapeutics, Inc.
 Q Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Q Therapeutics, Inc. engages in developing adult stem cell therapies to treat debilitating disease of the central nervous system. Its product, Q-Cells will undergo first-in-human trials for ALS. The firm’s therapeutic strategy is intended to restore the normal activity of neurons by providing the support functions present in healthy central nervous system tissue. The company was founded by Dennis B. Farrar, Mahendra S. Rao, Mani Ramaswami, and Steven Goldman on March 28, 2002 and is headquartered in Salt Lake City, UT. | Direttore/Membro del Consiglio | 06/12/2011 |
| P. E. Grebow Consulting, Inc. | Fondatore | 01/01/2011 |
MAGiQ Therapeutics, Inc.
 MAGiQ Therapeutics, Inc. BiotechnologyHealth Technology MAGiQ Therapeutics, Inc. develops biotechnologies and therapeutics. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Peter E. Grebow
| Società | Posizione | Fine |
|---|---|---|
| REBUS HOLDINGS, INC. | Presidente | 09/02/2018 |
Optimer Pharmaceuticals LLC
 Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | Direttore/Membro del Consiglio | 24/10/2013 |
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Corporate Officer/Principal | 01/04/2010 |
| Rhone-Poulenc Rorer Pharmaceuticals, Inc. | Corporate Officer/Principal | 01/01/1990 |
| EAGLE PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Peter E. Grebow
| Rutgers State University of New Jersey | Graduate Degree |
| Cornell University | Undergraduate Degree |
| University of California, Santa Barbara | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| EAGLE PHARMACEUTICALS, INC. | Health Technology |
| REBUS HOLDINGS, INC. | Health Technology |
| Aziende private | 7 |
|---|---|
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Health Technology |
Q Therapeutics, Inc.
Q Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Q Therapeutics, Inc. engages in developing adult stem cell therapies to treat debilitating disease of the central nervous system. Its product, Q-Cells will undergo first-in-human trials for ALS. The firm’s therapeutic strategy is intended to restore the normal activity of neurons by providing the support functions present in healthy central nervous system tissue. The company was founded by Dennis B. Farrar, Mahendra S. Rao, Mani Ramaswami, and Steven Goldman on March 28, 2002 and is headquartered in Salt Lake City, UT. | Health Technology |
Optimer Pharmaceuticals LLC
Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | Health Technology |
| Rhone-Poulenc Rorer Pharmaceuticals, Inc. | |
Complexa, Inc.
 Complexa, Inc. Pharmaceuticals: MajorHealth Technology Complexa, Inc. operates as a biopharmaceutical company which engages on discovering and developing therapies for the treatment of severe and life-threatening fibrosis and inflammatory diseases. The firm focuses on two therapeutic areas: focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH), two rare diseases that can compromise the normal function of the kidney and the heart. The company was founded by Bruce A. Freeman, Raymond A. Miller, and Margaret M. Tarpey in 2008 and is headquartered in Berwyn, PA. | Health Technology |
MAGiQ Therapeutics, Inc.
MAGiQ Therapeutics, Inc. BiotechnologyHealth Technology MAGiQ Therapeutics, Inc. develops biotechnologies and therapeutics. | Health Technology |
| P. E. Grebow Consulting, Inc. |
- Borsa valori
- Insiders
- Peter E. Grebow
